TickerFacts.

Camp4 Therapeutics Corp (CAMP): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$2.65
Year ended 2025-12-31
2023-12-31: -$124.802024-12-31: -$11.042025-12-31: -$2.65-$2.65
2023-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$2.65n/m2026-03-05, From 2025-01-01
2024-12-31-$11.04n/m2026-03-05, From 2024-01-01
2023-12-31-$124.80n/a2025-03-27, From 2023-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Camp4 Therapeutics Corp (CAMP)2025-12-31-$2.65n/m
Marker Therapeutics, Inc. (MRKR)2025-12-31-$0.79n/m
TherapeuticsMD, Inc. (TXMD)2025-12-31-$0.05n/m
Xenetic Biosciences, Inc. (XBIO)2025-12-31-$1.58n/m
China Pharma Holdings, Inc. (CPHI)2025-12-31-$0.74n/m
Upstream Bio, Inc. (UPB)2025-12-31-$2.66n/m
ProPhase Labs, Inc. (PRPH)2025-12-31-$1.74n/m
Cartesian Therapeutics, Inc. (RNAC)2025-12-31-$5.02n/m
Ensysce Biosciences, Inc. (ENSC)2025-12-31-$3.98n/m

Compare CAMP, MRKR, TXMD, XBIO side by side · Screen every company in Pharmaceutical Preparations ↗